Technical Comment on "Inhibition mechanism of NKCC1 involves the carboxyl terminus and long-range conformational coupling".
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
14 07 2023
14 07 2023
Historique:
medline:
14
7
2023
pubmed:
12
7
2023
entrez:
12
7
2023
Statut:
ppublish
Résumé
Flygaard, Habeck and Nissen question claims on bumetanide and furosemide binding to sodium-potassium-chloride cotransporter NKCC1.
Identifiants
pubmed: 37436990
doi: 10.1126/sciadv.adh0821
pmc: PMC10337923
doi:
Substances chimiques
Bumetanide
0Y2S3XUQ5H
Furosemide
7LXU5N7ZO5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
eadh0821Références
Sci Adv. 2022 Oct 28;8(43):eabq0952
pubmed: 36306358
Nature. 2019 Aug;572(7770):488-492
pubmed: 31367042
Neuropharmacology. 2018 Dec;143:186-204
pubmed: 30248303
Nat Commun. 2022 May 18;13(1):2747
pubmed: 35585053
EMBO J. 2021 Jul 15;40(14):e107294
pubmed: 34031912
EMBO J. 2022 Dec 1;41(23):e110169
pubmed: 36239040